Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                News & Events

News & Events

                        


                        FDA Meetings, Conferences and Workshops
          OTP Events, Meetings, and Workshops
          Rumor Control
          Approvals of FDA-Regulated Products
          Congressional Testimony
          FDA Newsroom
          Interactive and Social Media
          Public Health Focus
          Speeches by FDA Officials Home
          News & Events
          Natural History Studies to Support Regenerative Medicine: A How-To Webinar - 10/27/2022News & Events Workshop
    Event Title
              Natural History Studies to Support Regenerative Medicine: A How-To Webinar


                  October 27, 2022

  

    
  Share
    Post
    Linkedin

    Email
    PrintOn This Page
      Meeting Information
                Event MaterialsDate:
          
  


     
           

October 27, 2022   

 
 
        
                                      Time: 
                                      
11:00 AM
    - 1:00 PM
ET

 

  The FDA Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) hosted a public webinar on Thursday, October 27, from 11:00 a.m. to 1:00 p.m. ET.

“Natural History Studies to Support Regenerative Medicine: A How-To Webinar” brought together researchers, patients, caregivers, advocates, and other important stakeholders to discuss how to organize and execute natural history studies. This event continued the theme of the Annual Patient Engagement & Regenerative Medicine Meeting 2022: An FDA CBER Workshop for Patient Advocates, held on May 24, 2022, which focused on the importance of natural history studies and how they contribute to improved understanding of rare diseases and to development of regenerative medicine products such as gene and cell therapies.

Natural history studies follow a group of patients over time to collect health information on a particular disease. These studies can play an invaluable role in facilitating greater understanding of diseases by helping to inform clinical trials.

Graphic with DNA Helix. Text on graphic: Natural History Studies to Support Regenerative Medicine: A How-To Webinar   October 27, 2022 from 11:00 a.m. to 1:00 p.m. ET   #RegenMedEd
About the Webinar

The webinar featured a variety of speakers and panelists to discuss:

The importance of natural history studies and how they can be used to further rare disease drug development and clinical research
	How to conduct a well-designed natural history study from beginning to end
	Perspectives from researchers, patients, and advocates with firsthand experience organizing, executing, and participating in natural history studiesView the recording: Natural History Studies to Support Regenerative Medicine: A How-To Webinar

What is Regenerative Medicine?

Regenerative medicine therapies, such as cell and gene therapies, hold promise for transforming medicine and creating options for patients living with difficult, rare, and often incurable diseases. FDA plays a vital role in facilitating the development of regenerative medicine therapies, as well as in ensuring approved products are safe and effective for patients.

About the RegenMedEd Webinar Series

This webinar is part of an educational webinar series, “RegenMedEd: An FDA CBER OTAT Webinar Series on Regenerative Medicine.” The RegenMedEd webinar series aims to bring together important stakeholders and FDA staff to discuss foundational information about regenerative medicine therapies, such as gene therapy and cell therapy, and explore opportunities for patients, caregivers, and advocates to engage with FDA to help advance drug development.







Event Materials

  Title
            File Type/SizeNatural History Studies to Support Regenerative Medicine: A How-To Webinar - Slide Deck
              pdf               (3.05 MB)Natural History Studies to Support Regenerative Medicine: A How-To Webinar - Transcript
              pdf               (436.71 KB)

                                                                                  Content current as of:
      01/09/2023More Meetings,
      Conferences, and
      Workshops
        
        News & Events

          
                        


                        FDA Meetings, Conferences and Workshops
          OTP Events, Meetings, and Workshops
          Rumor Control
          Approvals of FDA-Regulated Products
          Congressional Testimony
          FDA Newsroom
          Interactive and Social Media
          Public Health Focus
          Speeches by FDA Officials
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop